Location History:
- Abiko, JP (2002 - 2003)
- Noda, JP (2003 - 2008)
- Nagareyama, JP (2011)
Company Filing History:
Years Active: 2002-2011
Title: **Keisuke Ohta: Innovator in Pharmaceutical Chemistry**
Introduction
Keisuke Ohta, a prominent inventor based in Noda, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a total of 12 patents to his name, Ohta focuses on developing novel methods and compounds to combat serious medical conditions, particularly tumors.
Latest Patents
Among Ohta's latest innovative works are patents relating to sulfonated sugar compounds and their applications in pharmaceutical compositions. His methods for treating tumors utilize sulfoquinovosylacyl propanediol compounds, which are crafted for effectiveness against various types of cancers. Specifically, these sulfur-containing compounds represented by a defined formula have shown potential in treating tumors, highlighting Ohta's role in advancing medical treatments.
Another significant patent involves a method for treating adenocarcinoma, which excludes colon, lung, and gastric cancers. This method comprises administering a pharmaceutically effective amount of sulfoquinovosylacylglycerol compounds, showcasing the innovative approaches Ohta employs in cancer therapy.
Career Highlights
Keisuke Ohta is affiliated with Toyo Suisan Kaisha, Ltd., where he continues to drive research and development in pharmaceutical innovations. His career is marked by a dedication to uncovering effective treatments that leverage his extensive knowledge in chemistry and pharmaceutical science.
Collaborations
Throughout his career, Ohta has collaborated with notable colleagues such as Takayuki Yamazaki and Fumio Sugawara. These partnerships have contributed to a synergistic environment fostering innovation and the successful development of new pharmaceutical compositions and treatments.
Conclusion
In summary, Keisuke Ohta’s work in the realm of pharmaceutical chemistry has had a profound impact on cancer treatment methodologies. With a strong portfolio of patents and collaborations with esteemed colleagues, Ohta continues to be a driving force in the innovation landscape of medicinal chemistry.